Ultragenyx Pharmaceutical
RARE
RARE
225 hedge funds and large institutions have $3.14B invested in Ultragenyx Pharmaceutical in 2022 Q4 according to their latest regulatory filings, with 35 funds opening new positions, 103 increasing their positions, 60 reducing their positions, and 40 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
225
Holders Change
-6
Holders Change %
-2.6%
% of All Funds
3.63%
Holding in Top 10
3
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+200%
% of All Funds
0.05%
New
35
Increased
103
Reduced
60
Closed
40
Calls
$18.3M
Puts
$16M
Net Calls
+$2.28M
Net Calls Change
-$641K
Top Buyers
1 |
RI
RTW Investments
New York
|
$184M |
2 |
APM
Avidity Partners Management
Dallas,
Texas
|
$139M |
3 |
SCM
Suvretta Capital Management
New York
|
$37.9M |
4 |
Millennium Management
New York
|
$35.8M |
5 |
First Trust Advisors
Wheaton,
Illinois
|
$53M |